A Community Intervention Trial of Multimodal Suicide Prevention Program in Japan (NOCOMIT-J) (NOCOMIT-J)

  1. The primary goal for this study is to examine the effectiveness of community-based multimodal intervention program for suicide prevention in relatively high suicide rate region compared to control region.
  2. The secondary goal for this study is to explore the effectiveness of community-based multimodal intervention program for suicide prevention in the highly populated regions. In addition, we examine the effectiveness of the prevention program in the all regions combined.

Study Overview

Detailed Description

Suicide is a major public health problem and the number of suicide victims has exceeded 30,000 a year since 1998 in Japan. Suicide rate is almost 25/100,000, which are remarkably high numbers among advanced countries. To examine the effectiveness of community-based multimodal intervention program for suicide prevention, a trial by J-MISP (Japanese Multimodal Intervention Trials for Suicide Prevention). This research project is one of the strategic research projects funded by The Japanese Ministry of Health, Labor and Welfare.

Study Type

Interventional

Enrollment (Actual)

1951060

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Akita, Japan
        • Akita region group
      • Aomori, Japan
        • Aomori region gruop
      • Kagoshima and Miyazaki, Japan
        • Minami Kyusyu region group
    • Chiba
      • Ichikawa, Chiba, Japan
        • Chiba region group
    • Fukuoka
      • Kitakyusyu, Fukuoka, Japan
        • Kita-Kyusyu region group
    • Iwate
      • Morioka, Iwate, Japan
        • Iwate region group
    • Miyagi
      • Sendai, Miyagi, Japan
        • Sendai region group

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Areas which meet the following criteria are eligible for this study;

    • An area with firm support from local government and other organizations to conduct this multimodal suicide prevention program
    • An area capable to select intervention and control regions
    • An area capable to follow the data collection procedure described in the protocol
    • An area with comparable baseline data on suicide attempts rate in intervention and control region
    • An area with comparable baseline data on demographics in intervention and control region

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Multimodal community intervention
Multimodal suicide prevention program

A community intervention of multimodal suicide prevention program includes following components:

  1. Building support networks for suicide prevention and mental health promotion in public health system
  2. Primary prevention of suicide and suicide related behaviors
  3. Secondary prevention of suicide and suicide related behaviors
  4. Tertiary prevention; after care for suicide survivors
  5. Suicide prevention targeting for people with substance/alcohol- related disorders , schizophrenia and other mental health disorders
  6. Suicide prevention targeting for people with work-related problems
Active Comparator: Community intervention as usual
Suicide prevention program as usual
Usual suicide prevention program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Incidence of suicide attempts (completed suicides and suicide attempts except mild case )
Time Frame: 3.5years
3.5years

Secondary Outcome Measures

Outcome Measure
Time Frame
Incidence of completed suicides
Time Frame: 3.5years
3.5years
Incidence of suicide attempts
Time Frame: 3.5 years
3.5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yutaka Ono, MD,PhD, Keio University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2006

Primary Completion (Actual)

December 1, 2009

Study Completion (Actual)

March 1, 2011

Study Registration Dates

First Submitted

August 15, 2008

First Submitted That Met QC Criteria

August 15, 2008

First Posted (Estimate)

August 18, 2008

Study Record Updates

Last Update Posted (Estimate)

October 31, 2013

Last Update Submitted That Met QC Criteria

October 30, 2013

Last Verified

October 1, 2013

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • J-MISP-02
  • UMIN000000460 (Registry Identifier: UMIN-CTR)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicide

Clinical Trials on Multimodal suicide prevention program

3
Subscribe